688739 成大生物
已收盘 11-06 15:00:00
资讯
新帖
简况
成大生物（688739）2026年三季报简析：净利润同比下降40.54%
证券之星 · 10-31
成大生物（688739）2026年三季报简析：净利润同比下降40.54%
成大生物（688739）10月30日主力资金净卖出176.83万元
证券之星 · 10-31
成大生物（688739）10月30日主力资金净卖出176.83万元
成大生物(688739)9月30日股东户数2.49万户，较上期增加8.2%
证券之星 · 10-30
成大生物(688739)9月30日股东户数2.49万户，较上期增加8.2%
图解成大生物三季报：第三季度单季净利润同比增长52.20%
证券之星 · 10-30
图解成大生物三季报：第三季度单季净利润同比增长52.20%
股市必读：成大生物新发布《辽宁恒信（沈阳）律师事务所关于辽宁成大生物股份有限公司2026年第二次临时股东会的法律意见书》
证券之星 · 10-15
股市必读：成大生物新发布《辽宁恒信（沈阳）律师事务所关于辽宁成大生物股份有限公司2026年第二次临时股东会的法律意见书》
股市必读：成大生物新发布《辽宁恒信（沈阳）律师事务所关于辽宁成大生物股份有限公司2026年第二次临时股东会的法律意见书》
证券之星 · 10-14
股市必读：成大生物新发布《辽宁恒信（沈阳）律师事务所关于辽宁成大生物股份有限公司2026年第二次临时股东会的法律意见书》
成大生物（688739）披露注销部分回购股份并减少注册资本公告，10月13日股价下跌0.62%
证券之星 · 10-13
成大生物（688739）披露注销部分回购股份并减少注册资本公告，10月13日股价下跌0.62%
成大生物：2026年第二次临时股东会决议公告
同花顺 · 10-13
成大生物：2026年第二次临时股东会决议公告
股市必读：成大生物新发布《辽宁成大生物股份有限公司2026年第二次临时股东会会议资料》
证券之星 · 10-08
股市必读：成大生物新发布《辽宁成大生物股份有限公司2026年第二次临时股东会会议资料》
成大生物：加快新产品商业化落地
证券之星 · 09-30
成大生物：加快新产品商业化落地
成大生物（688739）披露关于变更回购股份用途并注销暨减少注册资本的议案，9月24日股价下跌1.43%
证券之星 · 09-24
成大生物（688739）披露关于变更回购股份用途并注销暨减少注册资本的议案，9月24日股价下跌1.43%
成大生物最新公告：签订重组四价肠道病毒疫苗技术转让合同
证券之星 · 09-24
成大生物最新公告：签订重组四价肠道病毒疫苗技术转让合同
股市必读：成大生物新发布《辽宁成大生物股份有限公司高级管理人员减持股份计划时间届满暨减持结果的公告》
证券之星 · 09-23
股市必读：成大生物新发布《辽宁成大生物股份有限公司高级管理人员减持股份计划时间届满暨减持结果的公告》
每周股票复盘：成大生物（688739）Q2营收增15.94%
证券之星 · 08-30
每周股票复盘：成大生物（688739）Q2营收增15.94%
成大生物：公司全资子公司上海成大致远医药科技有限公司已完成工商注册
证券之星 · 08-28
成大生物：公司全资子公司上海成大致远医药科技有限公司已完成工商注册
成大生物：2026年上半年实现营业收入6.77亿元
证券之星 · 08-28
成大生物：2026年上半年实现营业收入6.77亿元
成大生物：公司核心产品Vero狂犬疫苗国内销量止跌回升
证券之星 · 08-28
成大生物：公司核心产品Vero狂犬疫苗国内销量止跌回升
股市必读：成大生物中报 - 第二季度单季净利润同比下降29.73%
证券之星 · 08-26
股市必读：成大生物中报 - 第二季度单季净利润同比下降29.73%
成大生物（688739）2026年中报简析：净利润同比下降72.79%
证券之星 · 08-26
成大生物（688739）2026年中报简析：净利润同比下降72.79%
成大生物(688739)6月30日股东户数2.3万户，较上期减少4.11%
证券之星 · 08-25
成大生物(688739)6月30日股东户数2.3万户，较上期减少4.11%
加载更多
公司概况
公司名称：
辽宁成大生物股份有限公司
所属行业：
医药制造业
上市日期：
2021-10-28
主营业务：
辽宁成大生物股份有限公司的主营业务是人用疫苗的研发、生产和销售。公司的主要产品是人用狂犬病疫苗、人用乙脑灭活疫苗。
发行价格：
110.00
{"stockData":{"symbol":"688739","market":"SH","secType":"STK","nameCN":"成大生物","latestPrice":20.79,"timestamp":1793948400000,"preClose":20.96,"halted":0,"volume":1500174,"delay":0,"changeRate":-0.0081,"floatShares":416000000,"shares":416000000,"eps":0.1561,"marketStatus":"已收盘","change":-0.17,"latestTime":"11-06 15:00:00","open":20.88,"high":20.92,"low":20.6,"amount":31191300,"amplitude":0.0153,"askPrice":20.8,"askSize":10,"bidPrice":20.79,"bidSize":16,"shortable":0,"etf":0,"ttmEps":0.1561,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":5,"adr":0,"adjPreClose":20.96,"symbolType":"stock_kcb","openAndCloseTimeList":[[1793928600000,1793935800000],[1793941200000,1793948400000]],"highLimit":23.06,"lowLimit":18.86,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":416450000,"isCdr":false,"pbRate":0.92,"roa":"--","peRate":133.183857,"roe":"1.04%","epsLYR":0.32,"committee":0.020772,"marketValue":8658000000,"turnoverRate":0.0036,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-11-09。","afterMarket":{"amount":0,"volume":0,"close":20.79,"buyVolume":0,"sellVolume":0,"time":1793950437746,"indexStatus":"已收盘 11-06 15:30:00","preClose":20.96},"floatMarketCap":8658000000},"requestUrl":"/m/hq/s/688739","defaultTab":"news","newsList":[{"id":"2679222819","title":"成大生物（688739）2026年三季报简析：净利润同比下降40.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679222819","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679222819?lang=zh_cn&edition=full","pubTime":"2026-10-31 11:38","pubTimestamp":1793417882,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期成大生物发布2026年三季报。根据财报显示，成大生物净利润同比下降40.54%。截至本报告期末，公司营业总收入10.43亿元，同比下降4.8%，归母净利润9799.39万元，同比下降40.54%。按单季度数据看，第三季度营业总收入3.66亿元，同比下降5.94%，第三季度归母净利润6471.33万元，同比上升52.2%。去年的净利率为9.48%，算上全部成本后，公司产品或服务的附加值一般。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100024723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679226493","title":"成大生物（688739）10月30日主力资金净卖出176.83万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679226493","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679226493?lang=zh_cn&edition=full","pubTime":"2026-10-31 08:16","pubTimestamp":1793405785,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月30日收盘，成大生物报收于20.13元，上涨2.18%，换手率0.63%，成交量2.61万手，成交额5282.56万元。10月30日的资金流向数据方面，主力资金净流出176.83万元，占总成交额3.35%，游资资金净流出276.79万元，占总成交额5.24%，散户资金净流入453.62万元，占总成交额8.59%。成大生物主营业务：人用疫苗的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100018139.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679213606","title":"成大生物(688739)9月30日股东户数2.49万户，较上期增加8.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679213606","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679213606?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:15","pubTimestamp":1793358927,"startTime":"0","endTime":"0","summary":"证券之星消息，近日成大生物披露，截至2026年9月30日公司股东户数为2.49万户，较6月30日增加1886.0户，增幅为8.2%。在生物制品行业个股中，成大生物股东户数低于行业平均水平，截至9月30日，生物制品行业平均股东户数为3.67万户。从股价来看，2026年6月30日至2026年9月30日，成大生物区间涨幅为7.85%，在此期间股东户数增加1886.0户，增幅为8.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000046974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679239472","title":"图解成大生物三季报：第三季度单季净利润同比增长52.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679239472","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679239472?lang=zh_cn&edition=full","pubTime":"2026-10-30 04:24","pubTimestamp":1793305497,"startTime":"0","endTime":"0","summary":"证券之星消息，成大生物2026年三季报显示，前三季度公司主营收入10.43亿元，同比下降4.8%；归母净利润9799.39万元，同比下降40.54%；扣非净利润7510.81万元，同比下降44.31%；其中2026年第三季度，公司单季度主营收入3.66亿元，同比下降5.94%；单季度归母净利润6471.33万元，同比上升52.2%；单季度扣非净利润4827.48万元，同比上升46.81%；负债率3.98%，投资收益2087.38万元，财务费用-800.76万元，毛利率76.41%。财报数据概要请见下图:本文数据来源于成大生物2026年三季报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000006125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675324178","title":"股市必读：成大生物新发布《辽宁恒信（沈阳）律师事务所关于辽宁成大生物股份有限公司2026年第二次临时股东会的法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675324178","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675324178?lang=zh_cn&edition=full","pubTime":"2026-10-15 03:30","pubTimestamp":1792006232,"startTime":"0","endTime":"0","summary":"公司公告汇总辽宁恒信（沈阳）律师事务所关于辽宁成大生物股份有限公司2026年第二次临时股东会的法律意见书辽宁恒信（沈阳）律师事务所对公司2026年第二次临时股东会的召集召开程序、出席会议人员资格、召集人资格及表决程序、表决结果进行了见证。辽宁恒信（沈阳）律师事务所对本次会议出具法律意见书，认为会议召集、召开程序及表决结果合法有效。公司已于2026年9月24日和10月13日分别召开董事会及临时股东大会审议通过该事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500003648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600739","BK0077","BK0196","688739","BK0074","BK0185","BK0144","BK0028","BK0239","BK0250","BK0046","BK0188","BK0012","600201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675364326","title":"股市必读：成大生物新发布《辽宁恒信（沈阳）律师事务所关于辽宁成大生物股份有限公司2026年第二次临时股东会的法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675364326","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675364326?lang=zh_cn&edition=full","pubTime":"2026-10-14 03:04","pubTimestamp":1791918252,"startTime":"0","endTime":"0","summary":"公司公告汇总：公司召开2026年第二次临时股东会，审议通过变更回购股份用途并注销2,982,382股、减少注册资本至413,467,618元等三项议案。公司公告汇总辽宁恒信（沈阳）律师事务所关于辽宁成大生物股份有限公司2026年第二次临时股东会的法律意见书辽宁恒信（沈阳）律师事务所见证公司2026年第二次临时股东会的召集召开程序、出席会议人员资格、召集人资格及表决程序、表决结果。该事项已于2026年9月24日董事会及10月13日临时股东大会审议通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400002091.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0250","688739","BK0239","600201","BK0077","BK0185","BK0188","BK0074","BK0028","BK0196","BK0144","BK0046","600739"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675636896","title":"成大生物（688739）披露注销部分回购股份并减少注册资本公告，10月13日股价下跌0.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675636896","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675636896?lang=zh_cn&edition=full","pubTime":"2026-10-13 22:29","pubTimestamp":1791901756,"startTime":"0","endTime":"0","summary":"截至2026年10月13日收盘，成大生物报收于20.89元，较前一交易日下跌0.62%，最新总市值为87亿元。近日，辽宁成大生物股份有限公司发布《关于注销公司部分回购股份并减少注册资本暨通知债权人的公告》。公告显示，公司因变更回购股份用途，拟将已回购的2,982,382股股份予以注销，注册资本将由416,450,000元减至413,467,618元。公司已于2026年9月24日和10月13日分别召开董事会及临时股东大会审议通过该事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300040048.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675352135","title":"成大生物：2026年第二次临时股东会决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2675352135","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675352135?lang=zh_cn&edition=full","pubTime":"2026-10-13 20:53","pubTimestamp":1791895980,"startTime":"0","endTime":"0","summary":" 证券日报网讯 10月13日，成大生物发布公告称，公司于2026年10月13日召开2026年第二次临时股东会，审议通过《关于变更回购股份用途并注销暨减少注册资本的议案 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20261013/c680653443.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20261013/c680653443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["688739","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673782017","title":"股市必读：成大生物新发布《辽宁成大生物股份有限公司2026年第二次临时股东会会议资料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673782017","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673782017?lang=zh_cn&edition=full","pubTime":"2026-10-08 03:29","pubTimestamp":1791401350,"startTime":"0","endTime":"0","summary":"公司公告汇总辽宁成大生物股份有限公司2026年第二次临时股东会会议资料辽宁成大生物股份有限公司拟将已回购的2,982,382股股份用途由用于员工持股计划或股权激励变更为注销并减少注册资本，公司总股本将由416,450,000股减至413,467,618股；同时修订《公司章程》中关于注册资本、股份总数及经营范围表述，并提请股东大会审议；拟续聘致同会计师事务所为2026年度财务及内部控制审计机构，审计费用预计不超过70万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800001657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0185","BK0188","BK0144","BK0196","600739","BK0239","BK0077","BK0046","688739","BK0028","BK0074","BK0250","600201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671279929","title":"成大生物：加快新产品商业化落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2671279929","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671279929?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:36","pubTimestamp":1790753819,"startTime":"0","endTime":"0","summary":"证券之星消息，成大生物09月30日在投资者关系平台上答复投资者关心的问题。请正面回复，不要官话套话，请在档次为人的层次层面回答问题成大生物回复：尊敬的投资者，您好！对此，公司董事会已专题研究部署：一是加快新产品商业化落地，三价及四价流感疫苗相继获批上市，人用二倍体狂犬疫苗自 9 月起上市销售；公司Vero 细胞狂犬疫苗国内销量企稳回升、出口同比增长。二是落实投资者回报，持续推进现金分红与股份回购，维护股东权益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000019614.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669499556","title":"成大生物（688739）披露关于变更回购股份用途并注销暨减少注册资本的议案，9月24日股价下跌1.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669499556","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669499556?lang=zh_cn&edition=full","pubTime":"2026-09-24 22:28","pubTimestamp":1790260103,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，成大生物报收于20.62元，较前一交易日下跌1.43%，最新总市值为85.87亿元。会议审议《关于变更回购股份用途并注销暨减少注册资本的议案》《关于修订<公司章程>的议案》《关于续聘会计师事务所的议案》。其中，《关于变更回购股份用途并注销暨减少注册资本的议案》为特别决议议案，并对中小投资者单独计票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400041429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669469478","title":"成大生物最新公告：签订重组四价肠道病毒疫苗技术转让合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2669469478","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669469478?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:49","pubTimestamp":1790243349,"startTime":"0","endTime":"0","summary":"成大生物(688739.SH)公告称，公司与维尔泰克签署《重组四价肠道病毒疫苗技术转让合同》，受让重组四价肠道病毒疫苗(汉逊酵母)项目全部权益，技术转让费4600万元(含税)，依据里程碑分期支付；销售提成及销售里程碑奖励根据产品上市后销售情况支付。标的产品尚处研发早期阶段，后续临床试验、注册审批及商业化存在不确定性。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400031285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159646","BK0239","688739"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669129146","title":"股市必读：成大生物新发布《辽宁成大生物股份有限公司高级管理人员减持股份计划时间届满暨减持结果的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669129146","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669129146?lang=zh_cn&edition=full","pubTime":"2026-09-23 01:50","pubTimestamp":1790099425,"startTime":"0","endTime":"0","summary":"公司公告汇总辽宁成大生物股份有限公司高级管理人员减持股份计划时间届满暨减持结果的公告辽宁成大生物股份有限公司副总经理陈新先生原计划自2026年6月22日至9月21日通过集中竞价方式减持公司股份不超过131,000股，占公司总股本比例不超过0.03%。本次减持计划未设置最低减持数量和比例，实际减持情况与此前披露的计划一致，未违反相关法律法规及承诺。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300002347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0074","BK0144","BK0012","BK0077","BK0188","BK0185","BK0196","BK0046","600739","BK0250","BK0239","600201","BK0028","688739"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663456530","title":"每周股票复盘：成大生物（688739）Q2营收增15.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663456530","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663456530?lang=zh_cn&edition=full","pubTime":"2026-08-30 09:42","pubTimestamp":1788054131,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，成大生物报收于21.08元，较上周的20.68元上涨1.93%。本周，成大生物8月26日盘中最高价报21.46元。业绩披露要点：2026年第二季度主营收入4.04亿元，同比上升15.94%。股本股东变化截至2026年6月30日，公司股东户数为2.3万户，较3月31日减少987户，减幅4.11%。第二季度单季主营收入4.04亿元，同比上升15.94%；单季归母净利润3518.83万元，同比下降29.73%；单季扣非净利润3719.85万元，同比下降5.62%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000004656.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662063033","title":"成大生物：公司全资子公司上海成大致远医药科技有限公司已完成工商注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2662063033","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662063033?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:16","pubTimestamp":1787908562,"startTime":"0","endTime":"0","summary":"成大生物回复：尊敬的投资者您好：公司联合控股股东辽宁成大共同发起设立成大（大连）生物医药产业投资基金，基金总规模不超过10亿元，首期规模5.02亿元，已完成工商注册及私募基金备案。公司全资子公司上海成大致远医药科技有限公司已完成工商注册，创新药战略布局有序落地。若发生相关重大进展，公司将严格遵照监管规则及信息披露相关规定，通过法定信息披露渠道及时履行信息披露义务，敬请您关注公司公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800039434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","688739","BK0239","BK1161","BK1515","09939","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662006303","title":"成大生物：2026年上半年实现营业收入6.77亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2662006303","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662006303?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:16","pubTimestamp":1787908560,"startTime":"0","endTime":"0","summary":"证券之星消息，成大生物08月28日在投资者关系平台上答复投资者关心的问题。公司核心狂犬疫苗产品毛利率长期在90%以上，批签发数量位居行业前列。成大生物回复：尊敬的投资者您好：2026年上半年，公司实现营业收入6.77亿元，归属于母公司所有者净利润3,328.06万元。利润降幅大于营收，主要受增值税税收政策调整影响，营业成本费用上升、毛利率下滑等多重因素叠加所致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800039430.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662063771","title":"成大生物：公司核心产品Vero狂犬疫苗国内销量止跌回升","url":"https://stock-news.laohu8.com/highlight/detail?id=2662063771","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662063771?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:15","pubTimestamp":1787908558,"startTime":"0","endTime":"0","summary":"公司核心产品Vero狂犬疫苗国内销量止跌回升，出口同比增长11.50%；人用二倍体狂犬疫苗、三价/四价流感疫苗等新产品相继获批上市，创新药产业基金布局有序推进。后续公司将持续提升经营质量，统筹业务发展与股东回报，力争以良好业绩回报广大投资者。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800039425.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739","BK0239","159646"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662075075","title":"股市必读：成大生物中报 - 第二季度单季净利润同比下降29.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662075075","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662075075?lang=zh_cn&edition=full","pubTime":"2026-08-26 06:42","pubTimestamp":1787697763,"startTime":"0","endTime":"0","summary":"业绩披露要点：2026年中报显示归母净利润3328.06万元，同比下降72.79%；第二季度单季度归母净利润3518.83万元，同比下降29.73%。上半年实现营业收入67,726.58万元，净利润3,328.06万元；核心产品人用狂犬病疫苗出口增长11.50%；完成AI+疫苗研发联合实验室建设；实施股份回购并完成现金分红；持续优化治理结构，加强信息披露与投资者沟通。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600011637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662381750","title":"成大生物（688739）2026年中报简析：净利润同比下降72.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662381750","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662381750?lang=zh_cn&edition=full","pubTime":"2026-08-26 06:17","pubTimestamp":1787696271,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期成大生物发布2026年中报。根据财报显示，成大生物净利润同比下降72.79%。截至本报告期末，公司营业总收入6.77亿元，同比下降4.18%，归母净利润3328.06万元，同比下降72.79%。按单季度数据看，第二季度营业总收入4.04亿元，同比上升15.94%，第二季度归母净利润3518.83万元，同比下降29.73%。去年的净利率为9.48%，算上全部成本后，公司产品或服务的附加值一般。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600009666.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688739"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662386057","title":"成大生物(688739)6月30日股东户数2.3万户，较上期减少4.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662386057","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662386057?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:42","pubTimestamp":1787650932,"startTime":"0","endTime":"0","summary":"证券之星消息，近日成大生物披露，截至2026年6月30日公司股东户数为2.3万户，较3月31日减少987.0户，减幅为4.11%。在生物制品行业个股中，成大生物股东户数低于行业平均水平，截至6月30日，生物制品行业平均股东户数为3.55万户。从股价来看，2026年3月31日至2026年6月30日，成大生物区间跌幅为20.46%，在此期间股东户数减少987.0户，减幅为4.11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500036890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688739"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793996920974,"stockEarnings":[{"period":"1week","weight":0.0328},{"period":"1month","weight":-0.0109},{"period":"3month","weight":0.0112},{"period":"6month","weight":-0.1221},{"period":"1year","weight":-0.2386},{"period":"ytd","weight":-0.1892}],"compareEarnings":[{"period":"1week","weight":0.0139},{"period":"1month","weight":-0.0502},{"period":"3month","weight":-0.0738},{"period":"6month","weight":-0.127},{"period":"1year","weight":-0.0895},{"period":"ytd","weight":-0.0805}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"辽宁成大生物股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"24898人(较上一季度增加8.20%)","perCapita":"16726股","listingDate":"2021-10-28","address":"辽宁省沈阳市浑南区新放街1号","registeredCapital":"41645万元","survey":" 辽宁成大生物股份有限公司的主营业务是人用疫苗的研发、生产和销售。公司的主要产品是人用狂犬病疫苗、人用乙脑灭活疫苗。","listedPrice":110},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"成大生物(688739)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供成大生物(688739)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"成大生物,688739,成大生物股票,成大生物股票老虎,成大生物股票老虎国际,成大生物行情,成大生物股票行情,成大生物股价,成大生物股市,成大生物股票价格,成大生物股票交易,成大生物股票购买,成大生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"成大生物(688739)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供成大生物(688739)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}